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Abstract
Background: Cervical cancer is the most commonly diagnosed cancer and the leading cause of cancer mortality
among women in sub-Saharan Africa. Recent recommendations for cervical cancer primary prevention highlight
HPV vaccination, and secondary prevention through screening. However, few studies have examined the different
dimensions of health care access, and how these may influence screening behavior, especially in the context of
clinical preventive services.
Methods: Using the 2003 South Africa World Health Survey, we determined the prevalence of cervical cancer
screening with pelvic examinations and/or pap smears among women ages 18 years and older. We also examined
the association between multiple dimensions of health care access and screening focusing on the affordability,
availability, accessibility, accommodation and acceptability components.
Results: About 1 in 4 (25.3%, n = 65) of the women who attended a health care facility in the past year got
screened for cervical cancer. Screened women had a significantly higher number of health care providers available
compared with unscreened women (mean 125 vs.12, p-value <0.001), and were more likely to have seen a medical
doctor compared with nurses/midwives (73.1% vs. 45.9%, p-value = 0.003). In multivariable analysis, every unit
increase in the number of health care providers available increased the likelihood of screening by 1% (OR = 1.01,
95% CI: 1.00, 1.01). In addition, seeing a nurse/midwife compared to a medical doctor reduced the likelihood of
screening by 87% (OR = 0.13, 95% CI: 0.04, 0.42).
Conclusions: Our findings suggest that cost issues (affordability component) and other patient level factors
(captured in the acceptability, accessibility and accommodation components) were less important predictors of
screening compared with availability of physicians in this population. Meeting cervical cancer screening and HPV
vaccination goals will require significant investments in the health care workforce, improving health care worker
density in poor and rural areas, and improved training of the existing workforce.
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Background
Cervical cancer incidence and mortality rates are higher in
Africa compared to other parts of the world [1]. Cervical
cancer is also the most commonly diagnosed cancer and
the leading cause of cancer mortality among women in
Africa, with 99,000 new diagnoses and 60,000 deaths in
2012 [2]. Although the number of cases is expected to
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increase over the next several decades due to population
aging, most countries on the continent still lack comprehensive cervical cancer prevention programs [2,3]. Recent
recommendations from the World Health Organization
International Agency for Research on Cancer (WHO-IARC)
include a specific focus on primary prevention through
HPV prophylactic vaccination, and secondary prevention through screening in the context of an adequatelyresourced health system infrastructure [4,5].
It is well documented that a beleaguered and underresourced health care infrastructure is a fundamental cause
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of poor health and high mortality rates in sub-Saharan
Africa (SSA) [6-9]. Importantly, the success of any primary
or secondary disease prevention effort is intricately linked
with the quality and accessibility of health services. However, few studies have comprehensively studied the different dimensions of health care access, and how these may
influence health behavior, especially in the context of
clinical preventive services [10,11]. Cervical cancer is an
ideal case study for examining how different components
of health care access influence the utilization of preventive
services, as there are well-established and well-accepted
screening guidelines. For instance, a recent WHO report
indicates that over 80% of all countries had a comprehensive cancer control plan in place [12], in addition to the
WHO comprehensive cervical cancer control guide and
position papers focusing on cervical cancer prevention
guidelines [13,14]. Furthermore, South Africa is an ideal
setting for investigating access to health care as a multidimensional construct since it is one of the most developed countries in SSA and therefore more likely to have a
structured health care system.
In SSA, as well as other regions of the world, access to
health care is often misunderstood in discussions about
primary and secondary prevention of cancer. Most studies
focus on physical and economic access to care as the critical factors in explaining level of and disparities in cancer
screening [15-18]. However a more complete and sophisticated approach to the definition of access to care has
been missing. According to the Penchansky and Thomas
framework (1981,1984), health care access is a latent
construct with 5 key dimensions: affordability, availability,
accessibility, accommodation and acceptability [19,20].
Affordability refers to the ability and willingness to pay for
health service; availability refers to the number and type
of health care provider present; accessibility refers to the
geographic distance and convenience of travel to the
health care center; accommodation refers to the perception of adequacy of health care provider in terms of skills
or supplies; and acceptability refers to comfort with health
care provider characteristics and perceptions of inferior
treatment based on gender, ethnicity or social class. Together these dimensions provide a comprehensive approach to measuring access and understanding how these
health care dimensions influence health behaviors while
taking into account the cultural, social, economic and
physical factors that may influence the perceived benefit
of seeking care and the ability to obtain quality care.
Our analysis is focused on secondary prevention (i.e.,
cervical cancer screening with a pelvic examination and/
or a Pap test) of cervical cancer in South Africa. The
current WHO recommendation for primary prevention
of cervical cancer focuses on the use of HPV vaccination
for 9–13 year old girls worldwide, a cost-effective approach that could potentially prevent 70% of all new
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diagnoses of cervical cancer [13]. However, the full cost
of the HPV vaccine ranges between $39 and $300 in
high-income countries [21], and unless highly subsidized
in low-income countries, cost will be a major barrier to
wide availability and adoption [22,23]. Since the HPV
vaccine is a relatively new development, it may take
some time before it is widely adopted in resource poor
areas of SSA, and the success of HPV vaccination as a
primary prevention strategy requires deep integration
with the existing health care infrastructure. In addition,
secondary prevention using pelvic examinations with
Pap tests and pelvic examinations with visual inspection
and acetic acid (VIA) will continue to be part of a comprehensive cancer control strategy for millions of women
who are no longer eligible for HPV vaccination. It is
therefore important to examine the association between
all dimensions of health care access and cervical cancer
screening. These findings will contribute to our understanding of the importance of the health system in the
success of future primary or secondary prevention effort
for cervical cancer.

Methods
The South Africa World Health Survey (WHS) was conducted between 2002 and 2004. It was a cross-sectional
study of adults ages 18 years and older residing in households selected through a multistage cluster sampling
method. Further details of the WHS methodology have
been published previously, and is available online [24]. The
current analysis was based on de-identified and publicly
available WHS data and so was exempt from IRB review,
although the initial WHS study was approved by the WHO
ethical review board, and informed consent was obtained
from each study participant. The WHS data is available for
download to researchers after submitting a data request
through the World Health Survey website [24]. Study participants were administered a detailed in-person interview
that focused on multiple household and individual characteristics, risk factors, and health outcomes.
The outcome of interest in this analysis was selfreported cervical cancer screening based on the receipt
of a pelvic examination with or without a Pap test in
response to the questions: 1. “When was the last time
you had a pelvic examination, if ever? (By pelvic examination, I mean when a doctor or nurse examined your vagina and uterus?).” Only women who reported a pelvic
examination within the past 3 years were asked. 2. “The
last time you had the pelvic examination, did you have a
PAP smear test? (By PAP smear test, I mean did a doctor
or nurse use a swab or stick to wipe from inside your
vagina, take a sample and send it to a laboratory?).”
Cervical cancer screening in this analysis was defined as
receipt of a pelvic exam with or without a Pap test in
the past 3 years categorized as yes/no.
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Socio-demographic characteristics assessed from the
questionnaire included marital status (single, married/cohabiting, divorced/separated, widowed), education (primary
school or less, secondary school, or college and above), employment (government employee, non-government employee, self-employed, not working for pay), residential
region (rural, urban), and overall health (good, moderate,
poor). Household socioeconomic status (SES) was defined
based on a composite index of permanent household income indicators. This method has been widely used to
characterize SES in lower income countries where income
and educational level may not adequately capture the full
extent of an individual’s socio-economic status [25-27].
Principal components analysis (PCA) was performed on
data assessing ownership of assets such as refrigerators,
washing machines, mobile phones, chairs, tables, etc. A
household SES score was obtained from PCA analysis by
weighting each indicator by the coefficient of the first principal component, and each member of the household was
assigned the same SES. SES was categorized into quartiles
ranging from highest to lowest SES.
All 5 health care access dimensions from the Penchansky and Thomas framework were evaluated from the
WHS questionnaire. Questionnaire items regarding the
features of the health care system and participant experience were solicited only from women who had been to a
health care facility in the past 12 months for their own
health or for their children.
All analytic procedures accounted for the complex survey design by using sample weights and stratum codes
provided in the dataset, using SAS (version 9.4, SAS
Institute, Cary NC). Descriptive statistics were conducted
to examine differences between screened and unscreened
women by socio-demographic and health care access variables. Multivariable logistic regression was used to examine the association between each health care dimension
and cervical cancer screening in separate models, and
then simultaneously in a fully adjusted model.

Table 1 Socio-Demographic characteristics of screened
and unscreened Women, 2003 South Africa World
Health Survey

Results
A total of 1,236 women participated in the South Africa
WHS, and 274 (22.2%) of them had received a pelvic
exam with or without a pap test within the last 3 years.
Overall among all study participants, the majority of the
women had a secondary school education or less, and
only about 13% had at least a college degree (Table 1).
About 56% of the women resided in an urban area, and
almost 70% reported being in good overall health. Almost 70% of the women were currently unemployed for
pay, while a slight majority (28%) belonged to the lowest
household SES quartile.
There were significant differences between screened and
unscreened women with respect to education, marital
status, employment status, and household SES. Women

who had been screened were more likely to have a college
degree (30.0% vs. 7.9%, p = 0.001), more likely to be
married (47.8% vs. 33.0%, p = 0.001), and were less likely
to be unemployed for pay 49.5% vs. 71.7%, p = 0.001).
Among screened women, 30.8% belonged to the highest
SES quartile compared with only 17.1% of unscreened
women (p = 0.07).
Table 2 provides a list of the dimensions as well as the
South Africa WHS items used for measurement. Table 3
presents the distribution of the health care access
dimensions among participants, and is limited to women
who had been to a healthcare facility in the past 12 months
and responded to questions regarding the healthcare system. A total of 256 (21%) women ages 18–69 years had
been to a health care facility in the past 12 months for

Pelvic/Pap Screening
Variable

Total
Screened Unscreened p-value
(n = 1,236) (n = 274) (n = 918)

Age (years) Mean
(Std. Error)

38.3 (0.6)

36.2 (1.3)

37.3 (0.6)

0.001

Primary school or less 43.4

24.4

47.4

0.001

Secondary school

43.9

45.6

44.7

College or more

12.7

30.0

7.9

Never married

48.2

36.3

53.4

Married

35.6

47.8

33.0

Separated/Divorced

6.6

11.6

5.3

Widowed

9.6

4.3

8.2

Education (%)

Marital Status (%)
0.001

Region (%)
Rural

43.8

33.4

47.1

Urban

56.2

66.6

52.9

66.8

75.4

65.9

0.25

Overall Health (%)
Good
Moderate

23.6

17.1

24.4

Poor

9.7

7.6

9.7

8.8

17.8

6.5

0.44

Employment (%)
Government
Non-government

17.4

26.9

15.4

Self-employed

6.1

5.7

6.4

49.5

71.7

Unemployed for Pay 67.7

0.001

Household SES (%)
Q1-Low

27.6

25.7

28.0

Q2

26.5

20.5

28.4

Q3

25.9

23.0

26.5

Q4-High

19.9

30.8

17.1

0.07
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Table 2 Access to health care dimensions in the 2003 South Africa World Health Survey
Health Care Access Dimensions

Definition

WHS Item and Question Number

Affordability

Ability and willingness to pay for health
care provider charges

• Health insurance coverage (Q0600)

Availability

Presence of health care providers and type
of health care facilities

• Number of health care providers (Q7002)

• Household SES (Q0700)*
• Provider Type: Medical Doctor/Others (i.e. nurses,
midwives, traditional healers) (Q7302)
• Government/ Non-government facility (Q7301)

Accessibility

Accommodation

Acceptability

Geographic distance and convenience of
travel to health care center

• Travel time (Q7307)

Perception of adequacy of provider’s operation
in terms of skills, supplies or drugs

• Provider skills (Q7304)

Comfort with provider characteristic; Perception
of inferior treatment;

• Provider’s gender (Q7303)

• Travel mode (Q7308)
• Equipment (Q7305)
• Perceived worse treatment based on sex, social
class, or ethnic group (Q7328-7334)

*Household SES was created as a composite variable based on ownership of permanent household assets.

themselves or their children, and 25% of these women had
received a pelvic exam with or without a pap test within
the last 3 years. Overall, less than 5% of women who
attended a health care facility in the past year had a form
of health insurance. The average number of providers
available was 27.5, the majority of providers seen were
medical doctors (53.1%), and most of the health care facilities were government-run (67.9%). About 56% of the
women traveled for 25 minutes or less to get to the health
care facility, and the most common mode of travel was
public transport (40.3%). Over 90% of the women were
satisfied both with their provider’s skills, and with the
availability of medical equipment. Most of the health care
providers seen were female (53.8%), and very few participants reported feeling that they were treated worse due to
their gender (3.5%), social class (8.1%), or ethnicity (5.4%).
About 1 in 4 (25.4%, n = 65) of the women who attended
a health care facility in the past year got screened for
cervical cancer (Table 3). There were significant differences between screened and unscreened women in relation to the affordability, availability and accessibility
dimensions of health care access. In terms of affordability,
we observed no differences in health insurance status by
screening, although screened women tended to be in the
highest quartile of household SES compared to unscreened
women (p = 0.07). In terms of availability, screened women
had significantly higher number of health care providers
available compared with unscreened women (mean 125
vs.12, p = <0.001); they were more likely to visit nongovernment facilities (59.1% vs. 22.8%, p =0.002); and more
likely to have seen a medical doctor (73.1% vs. 45.9%,
p = 0.003). In terms of accessibility, screened women were
more likely to travel 25 minutes or less to the health care
facility (68.4% vs. 50.1%, p = 0.04), and were more likely to
have a private mode of transportation (47.2% vs. 16.4%,

p = 0.002). There were no differences observed between
screened and unscreened women with respect to accommodation or acceptability factors in bivariate analysis.
Multivariable logistic regression analyses were used to
investigate the association between each of the five health
care access dimensions and cervical cancer screening
(Table 4). We examined affordability factors and found no
association between household SES and health insurance
on cervical cancer screening (Model 1). All three availability factors were associated with screening (Model 2): a
higher number of health care providers was positively associated with screening (OR for 1 unit increase in number
of providers = 1.01, 95% CI 1.00, 1.01), seeing a nurse/
midwife was associated with a lower likelihood of getting
screened compared with seeing a medical doctor (OR =
0.33, 95% CI 0.12, 0.86), and visiting a non-government
facility was associated with a significant increase in likelihood of getting screened compared with visiting a governmental facility (OR = 2.56, 95% CI: 1.18-5.57). In the
accessibility dimension, public transportation (OR = 0.39,
95% CI 0.12, 1.32) or biking/walking (OR = 0.28, 95% CI:
0.09, 0.87) as the primary mode of transportation were
negatively associated with screening compared with private transportation (Model 3). We observed no association between accommodation and screening (Model 4).
In the acceptability dimension, perception of worse treatment based on personal gender and social class were not
associated with screening. Paradoxically, women who reported not being treated worse by their providers based
on their ethnicity were less likely to be screened compared
to those women who did perceive worse treatment based
on ethnicity (OR = 0.26, 95% CI: 0.08, 0.84) (Model 5).
In Model 6, all the health care access dimensions are
considered simultaneously in age-adjusted models. Only
the availability dimension of health care remained associated
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Table 3 Distribution of health care access dimensions
among women who visited a facility in past 12 months,
2003 South Africa World Health Survey
Pelvic/Pap Screening
Variable

Table 4 Multivariable associations between health care
access dimensions and pelvic/pap screening, 2003 South
Africa World Health Survey (Odds Ratios and 95%
Confidence Intervals)
Age-Adjusted1
OR (95% CI)

Total Sample Screened Unscreened p-value
(n = 256)
(n = 65)
(n = 191)

Fully-Adjusted2
OR (95% CI)

Affordability

Affordability
0.6

Health Insurance (%)

Household SES

5.1

Q4-High

Ref

Ref

94.8

Q3

1.16 (0.3-5.1)

0.79 (0.22-2.83)

Availability

Q2

0.34 (0.1-1.0)

0.57 (0.09-3.36)

Number of Health
Care providers

Q1-Low

0.59 (0.2-1.5)

0.98 (0.21-4.56)

Yes

Ref

Ref

No

1.87 (0.5-7.2)

0.72 (0.14-3.77)

1.01 (1.00-1.01)

1.01 (1.00-1.01)

Yes
No

Mean (Std. Error)

4.8
95.2

3.8
96.2

Health Insurance
27.5 (7)

125 (83)

12.4 (7)

<0.001
0.002

Facility type (%)
Government

67.9

40.9

77.1

Non-Government

32.1

59.1

22.8

Availability
# Health Care providers
0.003

Provider type (%)

Facility type

Medical Doctor

53.1

73.1

45.9

Government

Ref

Ref

Nurse/Midwife

41.2

19.6

49.0

Non-Government

2.56 (1.18-5.57)

1.22 (0.48-3.09)

Traditional healer

5.6

7.2

5.0

Medical Doctor

Ref

Ref

Others (Nurses/midwives)

0.33 (0.12-0.86)

0.13 (0.04-0.42)

<=25 minutes

Ref

Ref

>25 minutes

0.59 (0.28-1.26)

1.46 (0.58-3.71)

Private

Ref

Ref

Public

0.39 (0.12-1.32)

1.19 (0.47-2.97)

Bike/Walk

0.17 (0.05-0.57)

0.62 (0.15-2.64)

0.79 (0.19-3.32)

0.40 (0.02-9.65)

1.99 (0.60-6.63)

1.11 (0.04-20.1)

0.59 (0.23-1.55)

2.81 (1.33-5.92)

Provider type

Accessibility
0.04

Travel time (%)
<=25 minutes

55.6

68.4

50.1

>25 minutes

44.4

31.5

49.9

Accessibility
Travel time
0.002

Travel mode (%)
Private

24.7

47.2

16.4

Public

40.3

34.6

42.4

Bike/Walk

34.9

18.1

41.3

Travel mode

Accommodation
Provider Skills
adequate (% Yes)
Equipment
adequate (% Yes)

94.0
91.1

94.7
94.4

93.8
89.6

0.75
0.20

Accommodation
Provider Skills adequate
(Yes vs. No)

Acceptability
Provider Gender
(% Female)

53.8

43.4

58.0

0.19

Gender (% Worse
No vs. Yes)

3.5

3.0

3.3

0.86

Social class (%
8.1
Worse No vs. Yes)

6.1

8.2

0.49

Ethnicity (% Worse 5.4
No vs. Yes)

6.1

4.8

0.69

Equipment adequate
(Yes vs. No)
Acceptability
Provider Gender (Female v. Male)
Gender (Worse No vs. Yes)

1.19 (0.29-4.92)

2.11 (0.41-11.04)

Social class (Worse No vs. Yes)

2.63 (0.95-7.25)

4.03 (0.30-5.9)

Ethnicity (Worse No vs. Yes)

0.26 (0.08-0.84)

0.17 (0.01-3.82)

1

with screening. Every unit increase in the number of
health care providers available increased the likelihood
of screening by 1% (OR = 1.01, 95% CI: 1.00, 1.01). In
addition, seeing a nurse/midwife compared to a medical
doctor reduced the likelihood of screening by 87% (OR =
0.13, 95% CI: 0.04, 0.42) (Table 4, Model 6).

Each health care access dimension was assessed in separate models, adjusted
for age.
2
All health care dimension explanatory variables were combined in the fully
adjusted model, adjusted for age.

Discussion
Using the 2003 South Africa World Health Survey, we
examined the association between multiple dimensions
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of health care access and cervical cancer screening among
adult women. We observed that only about 1 out of 5
women included in this study had been screened for cervical cancer in the past 3 years. Among women who had
visited a health care facility in the past 12 months, our results suggest that availability, specifically the number of
health care providers available as well as the type of provider, was the most significant dimension of access to care
associated with screening. Every extra health care provider
available in the past year was associated with a 1% increase
in likelihood of cervical cancer screening; and a visit to a
non-physician health care provider (e.g. nurses, midwives,
traditional healers) in the past year was associated with
87% decline in likelihood of cervical cancer screening.
These associations remained even after adjusting for other
health care access components. We found no significant
association in adjusted models between cervical cancer
screening and affordability, accessibility, accommodation
and acceptability dimensions of access.
Multiple studies have examined screening rates and factors associated with cervical cancer screening across
several African countries [10,11,28-36], with reported cervical cancer screening rates as low as 6% in Kenya [36]
and 12% in Uganda [35] among adult women. Our observed screening rate of 20% is similar to rates reported in
other studies for South Africa [37,38], and only slightly
better than other sub-Saharan African countries [39,40].
However, these numbers likely mask large within-country
differences in screening rates. For instance, Maree et al.
[41] observed that only 4% of women targeted for cervical
cancer screening in a poor region of South Africa actually
received screening. More recent figures from a separate
analysis by Adonis et al. in 2012 revealed a similar picture
in South Africa [42]; while prostate cancer screening rates
were close to 40% among adult men, the highest cervical
cancer screening rate observed was 23% in Gauteng province, compared with 13% in Northern Cape [42].
Several studies have also investigated barriers to cancer
screening in general, and cervical cancer screening specifically [28,30,33,35] among African women. The most common barriers to routine screening highlighted in these
studies include lack of knowledge about cervical cancer or
screening, fear of abnormal results, cost and lack of
adequate medical infrastructure and personnel. Our study
adds an important component to this area of research
by highlighting specific dimensions of health care access
that may be important target areas for policies designed
to facilitate cancer screening. We found no association
between our affordability component and health care
screening and no significant results for the accessibility,
accommodation, and acceptability components. We did
observe that access to a higher number of physicians significantly predicted receipt of cervical cancer screening.
Our finding that cost issues (affordability component) and
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other patient level factors (captured in the acceptability
and accommodation components) were less important
predictors of screening compared with availability of physicians and physician recommendation has also been observed in prior studies of populations eligible for free
cancer screening [43,44].
There were several strengths and limitations of this
analysis. First, the study benefited from the standardized
protocol used in the World Health Survey, and the stratified clustered sampling technique that ensured representation of participants across South Africa. Secondly, the
use of a composite measure of SES contributes to the literature by providing a more robust measure useful in
areas where income and education may not fully capture
the full extent of an individual/household SES. A limitation of this study is the use of questionnaire data to solicit
information, and which may be vulnerable to recall and/or
information bias. However, since these questions were
part of a larger survey assessing a range of health behaviors, we do not anticipate a high likelihood of socially desirable answers to questions relating to cervical cancer
screening. In addition, we were unable to examine results
based on if care was being sought for a child or for an
adult. It is likely that perceptions about healthcare quality
will differ depending on the type of clinic attended (e.g.
pediatric or reproductive clinic), or depending on who is
receiving care. Finally, the data used for this analysis were
collected between 2002 and 2004, and while certain aspects may have changed in the interim, our results provides a deeper understanding of structural issues relating
to availability, accessibility, accommodation and acceptability that often take many decades to resolve. Recent
studies conducted between 2011 and 2013 indicate that
cervical cancer screening rates are still very low in South
Africa [37,41,42].
We based our outcome measure on a combined item
assessing pelvic examinations with or without a Pap test.
Although the questionnaire was designed to assess cervical cancer screening, it is possible that a pelvic examination was done outside the context of cervical cancer
screening. However, we observed that of the 274 women
who received a pelvic exam, 210 had also reported receiving a Pap test suggesting that the majority of pelvic
examinations were being done in the context of cervical
cancer screening. We ran a sensitivity analysis on the
210 women who received a Pap test to determine if the
regression results would change, yet found similar results. Therefore, we present results based on the analysis
of the full set of 274 women assumed to have received a
form of cervical cancer screening in South Africa.
Many African countries have very few medical doctors
in relation to their population, with some countries well
below the WHO minimum of 23 health care workers
per 10,000 [45]. These shortages are driven mainly by
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‘brain drain’ of health professionals to developed countries, and because existing health care workers also tend
to cluster in urban, highly developed areas of the country, leaving the poor, rural areas underserved. An attempt to address this issue has led to ‘task-shifting’, in
which professional nurses are tasked with performing
the bulk of routine medical care and screening [46,47].
This has had limited success in South Africa, as reflected
in the persistently low cervical cancer screening rates,
and the significantly lower likelihood of getting screened
if women are seeing non-physician providers. This suggests that meeting cervical cancer screening goals and
the success of HPV vaccination programs requires significant investments in the health care workforce, improving health care worker density in poor and rural
areas, and improved training of the existing workforce.

Conclusions
Cervical cancer screening rates in South Africa are much
lower than the national screening goal or targets set by
the WHO. This is likely due to a lack of available healthcare providers, especially medical doctors, which in turn
reduces screening access for women eligible for screening.
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